Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update

Clearmind Medicine Inc. (NASDAQ:CMND) was the target of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 620,700 shares, an increase of 453.7% from the December 31st total of 112,100 shares. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is currently 0.5 days. Currently, 21.0% of the shares of the company are short sold.

Clearmind Medicine Stock Up 0.4 %

NASDAQ CMND opened at $1.37 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.71 and a quick ratio of 1.71. Clearmind Medicine has a 1-year low of $0.95 and a 1-year high of $2.30. The business’s fifty day moving average price is $1.41 and its 200-day moving average price is $1.40.

Clearmind Medicine (NASDAQ:CMND) last issued its quarterly earnings data on Wednesday, January 22nd. The company reported ($0.11) earnings per share for the quarter.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.